Per Hildebrandt

13.5k total citations · 2 hit papers
170 papers, 8.5k citations indexed

About

Per Hildebrandt is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Per Hildebrandt has authored 170 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Cardiology and Cardiovascular Medicine, 28 papers in Endocrinology, Diabetes and Metabolism and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Per Hildebrandt's work include Heart Failure Treatment and Management (77 papers), Cardiovascular Function and Risk Factors (60 papers) and Acute Myocardial Infarction Research (21 papers). Per Hildebrandt is often cited by papers focused on Heart Failure Treatment and Management (77 papers), Cardiovascular Function and Risk Factors (60 papers) and Acute Myocardial Infarction Research (21 papers). Per Hildebrandt collaborates with scholars based in Denmark, United States and Norway. Per Hildebrandt's co-authors include Finn Gustafsson, Lars Køber, Caroline Kistorp, Jens Faber, Christian Torp‐Pedersen, Morten Schou, Charlotte Kragelund, Rolf Steffensen, Bjørn Grønning and Bjoern A. Groenning and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Per Hildebrandt

169 papers receiving 8.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity

2005 728 citations Per Hildebrandt, Christian Torp‐Pedersen et al. profile →
Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart Failure

2005 503 citations Caroline Kistorp, Jens Faber et al. profile →

Peers

Countries citing papers authored by Per Hildebrandt

Since Specialization

Citations

This map shows the geographic impact of Per Hildebrandt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Hildebrandt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Hildebrandt more than expected).

Fields of papers citing papers by Per Hildebrandt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Hildebrandt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Hildebrandt. The network helps show where Per Hildebrandt may publish in the future.

Co-authorship network of co-authors of Per Hildebrandt

This figure shows the co-authorship network connecting the top 25 collaborators of Per Hildebrandt. A scholar is included among the top collaborators of Per Hildebrandt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per Hildebrandt. Per Hildebrandt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of Extended Follow-Up in a Specialized Heart Failure Clinic on Adherence to Guideline Recommended Therapy: NorthStar Adherence Study 2014 ·European Journal of Heart Failure ·Morten Schou, Gunnar Gislason, Lars Videbæk, Lars Køber, Christian Tuxen, Christian Torp‐Pedersen, Per Hildebrandt, Finn Gustafsson	19
2	Adding Serial N-Terminal Pro Brain Natriuretic Peptide Measurements to Optimal Clinical Management in Outpatients with Systolic Heart Failure: A Multicentre Randomized Clinical Trial (NorthStar Monitoring Study) 2013 ·European Journal of Heart Failure ·Morten Schou, Finn Gustafsson, Lars Videbæk, Helge Andersen, (unknown), Ole Nyvad, (unknown), Lars Fog, (unknown), Olav Wendelboe Nielsen, (unknown), Jawdat Abdulla, Per Hildebrandt	30
3	Patient Adherence to Evidence-Based Pharmacotherapy in Systolic Heart Failure and the Transition of Follow-Up from Specialized Heart Failure Outpatient Clinics to Primary Care 2013 ·European Journal of Heart Failure ·(unknown), Morten Schou, Christian Torp‐Pedersen, Lars Køber, Finn Gustafsson, Per Hildebrandt, Lars Videbæk, Henrik Wiggers, (unknown), Mette Charlot, Gunnar Gislason	35
4	α-Defensins and Outcome in Patients with Chronic Heart Failure 2012 ·European Journal of Heart Failure ·(unknown), Jan Frystyk, Jens Faber, Morten Schou, Allan Flyvbjerg, Per Hildebrandt, Ilan Raymond, Tobias Wirenfeldt Klausen, Caroline Kistorp	22
5	Prevalence and Prognostic Significance of Hyponatraemia in Outpatients with Chronic Heart Failure 2011 ·European Journal of Heart Failure ·Louise Balling, Morten Schou, Lars Videbæk, Per Hildebrandt, Henrik Wiggers, Finn Gustafsson	65
6	Complement activation, endothelial dysfunction, insulin resistance and chronic heart failure 2010 ·Scandinavian Cardiovascular Journal ·Mette Bjerre, Caroline Kistorp, Troels Krarup Hansen, Jens Faber, Gregory Y.H. Lip, Per Hildebrandt, Allan Flyvbjerg	14
7	Oral Glucose Tolerance Testing in an Outpatient Heart Failure Clinic Reveals a High Proportion of Undiagnosed Diabetic Patients with an Adverse Prognosis 2010 ·European Journal of Heart Failure ·Michael Egstrup, Morten Schou, Finn Gustafsson, Caroline Kistorp, Per Hildebrandt, Christian Tuxen	35
8	Incidence and Predictors of Hospitalization or Death in Patients Managed in Multidisciplinary Heart Failure Clinics 2009 ·European Journal of Heart Failure ·Finn Gustafsson, Morten Schou, Lars Videbæk, Nadia Dridi, (unknown), (unknown), Per Hildebrandt	18
9	Losartan versus atenolol on 24‐hour ambulatory blood pressure. A LIFE substudy 2007 ·Blood Pressure ·Lia E. Bang, Niels Wiinberg, Kristian Wachtell, (unknown), Michael Hecht Olsen, Christian Tuxen, Per Hildebrandt, Hans Ibsen	10
10	Treatment with Beta-Blockers in Nurse-Led Heart Failure Clinics: Titration Efficacy and Predictors of Failure 2007 ·European Journal of Heart Failure ·Finn Gustafsson, Morten Schou, Lars Videbæk, Tonny Nielsen, (unknown), John Markenvard, Tage Lysbo Svendsen, (unknown), (unknown), Per Hildebrandt	30
11	Unexplained Week-to-Week Variation in BNP and NT-proBNP is Low in Chronic Heart Failure Patients During Steady State 2006 ·European Journal of Heart Failure ·Morten Schou, Finn Gustafsson, Per Hostrup Nielsen, Lene Helleskov Madsen, Andreas Kjær, Per Hildebrandt	65
12	Prevalence and Prognostic Significance of Atrial Fibrillation in Outpatients With Heart Failure Due to Left Ventricular Systolic Dysfunction 2006 ·European Journal of Heart Failure ·Pernille Corell, Finn Gustafsson, Morten Schou, John Markenvard, Tonny Nielsen, Per Hildebrandt	58
13	Tolerability of Carvedilol and ACE-Inhibition in Mild Heart Failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN) 2004 ·European Journal of Heart Failure ·Michel Komajda, Beatrix Lutiger, Hugo Madeira, Kristian Thygesen, Marco Bobbio, Per Hildebrandt, Wybren Jaarsma, Günter A.J. Riegger, Lars Rydén, Armin Scherhag, Jordi Soler‐Soler, Willem J. Remme	55
14	N-Terminal Pro Brain Natriuretic Peptide in Arterial Hypertension—A Marker for Left Ventricular Dimensions and Prognosis 2004 ·European Journal of Heart Failure ·Per Hildebrandt, Mikael Boesen, Michael Hecht Olsen, Kristian Wachtell, Bjoern A. Groenning	54
15	[Hyperkalemia and impaired renal function in patients taking spironolactone for congestive heart failure. A retrospective analysis of 125 consecutive cases]. 2004 ·PubMed ·(unknown), Finn Gustafsson, Søren Galatius, Per Hildebrandt, Dan Atar	5
16	Echocardiographic Indices of Left Ventricular Diastolic Dysfunction in 647 Individuals with Preserved Left Ventricular Systolic Function 2004 ·European Journal of Heart Failure ·Frants Pedersen, Ilan Raymond, Lene Helleskov Madsen, Jesper Mehlsen, Dan Atar, Per Hildebrandt	17
17	[Establishment of a nurse-led heart failure clinic. Design and baseline data from the first two years]. 2003 ·PubMed ·Søren Galatius, Finn Gustafsson, Caroline Kistorp, Per Hostrup Nielsen, Dan Atar, Per Hildebrandt	2
18	Value of N-Terminal proBNP in the Diagnosis of Left Ventricular Systolic Dysfunction in Primary Care Patients Referred for Echocardiography 2003 ·Finn Gustafsson, (unknown), (unknown), (unknown), Per Hildebrandt	28
19	Basal and Exercise-Induced Neuroendocrine Activation in Patients with Heart Failure and in Normal Subjects 2003 ·European Journal of Heart Failure ·Andreas Kjær, (unknown), Per Hildebrandt, Claus Leth Petersen	35
20	The Frederiksberg Heart Failure Study: Rationale, Design and Methodology, with Special Emphasis on the Sampling Procedure for the Study Population and Its Comparison to the Background Population 2002 ·Ilan Raymond, Frants Pedersen, Michael Busch-Sørensen, Anders Green, Per Hildebrandt	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact